Patent Grant
11577076
In general, this application is directed uploading data from an isolated medical device without compromising isolation of the medical device. More specifically, the application is directed to a data transfer apparatus (“DTA”) for use with the medical device, which DTA facilitates remote monitoring of treatment using the medical device.
In general, TTFields (tumor-treating fields) therapy is a proven approach for treating tumors. In a prior art Optune® system for delivering TTFields as illustrated in
The field generator 14 includes an AC voltage generator 16 and a controller 18. The amplitude of the alternating current that is delivered via the transducer arrays 10 is controlled by the controller 18 so that skin temperature (as measured on the skin below the transducer arrays) does not exceed a safety threshold of 41 degrees Celsius. The temperature measurements on the patient's skin are obtained using thermistors (not shown) placed beneath some of the disks (not shown) of the transducer arrays 10. In the existing Optune® system, each array 10 includes 8 thermistors, with one thermistor positioned beneath a respective disk in the array.
The temperature from all 32 thermistors (4 arrays×8 thermistors per array) is measured and analog-to-digitally converted into digital values for each thermistor. These measurements are then transmitted from the transducer interface 20 to the field generator 14. The controller 18 in the field generator 14 uses the temperature measurements to control the current to be delivered via each pair of arrays 10 in order to maintain temperatures below 41 degrees Celsius on the patient's skin.
In the existing Optune® system, there are four long 10-wire cables 12, each of which runs between a respective array 10 and the transducer interface 20, and one 8-wire spiral cord (not illustrated specifically) that runs between the transducer interface 20 and the connector 28 on the field generator 14. Each of the 10-wire cables 12 has 8 wires for carrying signals from the 8 thermistors, 1 wire for the common of all 8 thermistors, plus 1 wire for providing the TTFields signal (i.e., current) to the array 10. The 8-wire spiral cord has 1 wire for power to the transducer interface 20 (Vcc), supplied by a power source in the field generator; 1 wire for ground to the transducer interface 20; 2 wires for serial data communication (to send the temperature readings from the transducer interface 20 to the field generator 14); plus 4 wires for TTFields signals (i.e., one signal for each of the four arrays 10). The 8-wire spiral cord has a second connector 26 at its end, which interfaces with the first connector 28 on the field generator 14.
Furthermore, so that a care provider can monitor a patient's course of treatment, the field generator 14 includes one or more data storage registers (i.e., memory) 30, where patient-treatment data is stored. Information in the treatment data may include, for example, time and date of treatment sessions; current applied by each transducer array 10; temperatures measured by the thermistors; any anomalies; etc. Currently, the treatment data that has been stored in the field generator can only be accessed by having the patient bringing the Optune® system to a facility, where technical staff accesses and downloads the data via a dedicated service-port.
The disclosed apparatus facilitates the transfer of data from an Optune® system to a remote facility without requiring the patient to transport the Optune® system. Thus, the disclosed apparatus features a data transfer apparatus (“DTA”) that connects to the field generator (where the patient-treatment data is stored) using the same single connector that was traditionally used to attach the transducer interface to the field generator. The field generator is configured to automatically determine whether the transducer interface or the DTA is connected to it. When the transducer interface is connected to the field generator, the field generator applies AC voltages to the transducer arrays (via the transducer interface) to deliver TTFields therapy to the patient. On the other hand, when the DTA is connected to the field generator, the field generator transfers the patient-treatment data to the DTA, and the DTA accepts the data from the field generator. Subsequently after the DTA has been disconnected from the field generator, the DTA transmits the data to a remote server, e.g., via the Internet (wirelessly or via wired connection) or via cellular data transmission.
Because the data is transmitted to the remote server, this arrangement eliminates the need for the patient to bring the Optune® system to a facility, which is a significant convenience for the patient. Furthermore, because the same single connector is used to attach the DTA or the transducer interface to the field generator, there is no risk of erroneously applying current from a DTA to the transducers (and hence to the patient). In other words, electrical isolation of the patient from signals other than those generated by the field generator is maintained. Further still, providing a DTA as a distinct device—in contrast to incorporating data transmission hardware into the field generator—avoids the need for data-transmission certification (e.g., by the Federal Communications Commission) in addition to medical-device certification (e.g., by the Food and Drug Administration).
One aspect of the invention is directed to a data transfer apparatus for use in association with a field generator of a TTFields (tumor-treating fields) therapy system. The field generator has a first connector that is used to output AC signals and convey serial data. The data transfer apparatus comprises a serial data transceiver; a memory; a modem; and a second connector configured to interface with the first connector. The data transfer apparatus also comprises a controller programmed to execute instructions that cause the data transfer apparatus to execute the following steps: (1) determining that the field generator has been connected to the data transfer apparatus; (2) after determining that the field generator has been connected to the data transfer apparatus, causing the serial data transceiver to accept serial data from the field generator and to store the accepted data in the memory, wherein the accepted data is data relating to treatment of a patient using TTFields; (3) after accepting the data from the field generator, determining whether the field generator has been disconnected from the data transfer apparatus; and (4) after determining that the field generator has been disconnected from the data transfer apparatus, retrieving data relating to treatment of a patient using TTFields from the memory and causing the modem to transmit the retrieved data to a remote server.
In some embodiments of the data transfer apparatus, the controller is programmed to cause the field generator to clear TTFields treatment-related data that has been stored in the field generator once all data relating to treatment of a patient using TTFields has been accepted.
In some embodiments of the data transfer apparatus, the modem is configured to transmit data via the Internet. In some embodiments of the data transfer apparatus, the modem is configured to transmit data via a cellular data network.
Some embodiments of the data transfer apparatus further comprise a switch that actuates upon physical connection of another device to the data transfer apparatus. In these embodiments, the controller is programmed to determine that the field generator has been connected to the data transfer apparatus by detecting a state of the switch. Optionally, in these embodiments, the controller is further programmed to determine that the field generator has been disconnected from the data transfer apparatus by detecting the state of the switch.
In some embodiments of the data transfer apparatus, the connection between the field generator and the data transfer apparatus interface is implemented by mating the second connector directly to the first connector.
In some embodiments of the data transfer apparatus, the connection between the field generator and the data transfer apparatus interface is implemented by connecting a cable between the second connector and the first connector.
Another aspect of the invention is directed to a TTFields (tumor-treating fields) therapy field generator. The field generator comprises an AC voltage generator; a serial data transceiver; a memory; and a single first connector having 1) a first plurality of pins for outputting an AC voltage generated by the AC voltage generator, and 2) a second plurality of pins for conveying serial data to and from the serial data transceiver. The field generator also comprises a controller programmed to execute instructions that cause the field generator to perform the following steps: (1) determining if a transducer interface has been connected to the first connector; (2) after determining that the transducer interface has been connected to the first connector, activating the AC voltage generator so that an AC voltage appears across the first plurality of pins of the first connector, and storing data relating to TTFields treatment in the memory; (3) determining if a data transfer apparatus has been connected to the first connector; and (4) after determining that a data transfer apparatus has been connected to the first connector, retrieving the data related to TTFields treatment from the memory and routing the retrieved data to the serial data transceiver so that the serial data transceiver outputs the data relating to TTFields treatment via the second plurality of pins of the single first connector.
In some embodiments of the field generator, the controller is programmed to determine that a transducer interface has been connected to the first connector by examining data received via the serial data transceiver.
In some embodiments of the field generator, the controller is programmed to determine that a data transfer apparatus has been connected to the first connector by examining data received via the serial data transceiver.
In some embodiments of the field generator, the controller is programmed to clear data relating to TTFields treatment from the memory after the data relating to TTFields treatment has been output by the serial data transceiver.
In some embodiments of the field generator, the data relating to TTFields therapy stored in the memory includes one or more of time and date of treatment sessions, current applied by each transducer array in a set of transducer arrays that has been connected to the first connector, measured temperature values, and operational anomalies.
Another aspect of the invention is directed to a TTFields (tumor-treating fields) therapy system with enhanced diagnostics. The system comprises a field generator; and a data transfer apparatus. The field generator includes an AC voltage generator, a first serial data transceiver, a first memory, a single first connector having 1) a first plurality of pins for outputting an AC voltage generated by the AC voltage generator, and 2) a second plurality of pins for conveying serial data to and from the first serial data transceiver, and a first controller. The first controller is programmed to execute instructions that cause the field generator to perform the following steps: (1) determining if a transducer interface has been connected to the first connector, (2) after determining that the transducer interface has been connected to the first connector, activating the AC voltage generator so that an AC voltage appears across the first plurality of pins of the first connector, and storing data relating to TTFields treatment in the first memory, (3) determining if a data transfer apparatus has been connected to the first connector, and (4) after determining that a data transfer apparatus has been connected to the first connector, retrieving the data related to TTFields treatment from the first memory and routing the retrieved data to the first serial data transceiver so that the first serial data transceiver outputs the data relating to TTFields treatment via the second plurality of pins of the single first connector. The data transfer apparatus includes a second serial data transceiver, a second memory, a modem, a second connector configured to interface with the first connector, and a second controller. The second controller is programmed to execute instructions that cause the data transfer apparatus to execute the following steps: (1) determining that the field generator has been connected to the data transfer apparatus, (2) after determining that the field generator has been connected to the data transfer apparatus, causing the second serial data transceiver to accept serial data from the field generator and to store the accepted data in the second memory, wherein the accepted data is data relating to treatment of a patient using TTFields, (3) after accepting the data from the field generator, determining whether the field generator has been disconnected from the data transfer apparatus, and (4) after determining that the field generator has been disconnected from the data transfer apparatus, retrieving data relating to treatment of a patient using TTFields from the second memory and causing the modem to transmit the retrieved data to a remote server.
In some embodiments of the system, the first controller is programmed to (a) determine that the transducer interface has been connected to the first connector by examining data received via the first serial data transceiver, and (b) determine that the data transfer apparatus has been connected to the first connector by examining data received via the first serial data transceiver.
In some embodiments of the system, the first controller is programmed to clear data relating to TTFields treatment from the first memory after the data relating to TTFields treatment has been output by the first serial data transceiver.
In some embodiments of the system, the data relating to TTFields therapy stored in the first memory includes one or more of time and date of treatment sessions, current applied by each transducer array in a set of transducer arrays that has been connected to the first connector, measured temperature values, and operational anomalies.
In some embodiments of the system, the connection between the field generator and the data transfer apparatus interface is implemented by mating the second connector directly to the first connector. In some embodiments of the system, the connection between the field generator and the data transfer apparatus interface is implemented by connecting a cable between the second connector and the first connector.
As illustrated in
The field generator connector 52 (also referred to herein as the “first connector”) is configured to interface with a transducer interface 20 via the second connector 26 of the transducer interface 20 as illustrated in
As illustrated in
The DTA 42 has a DTA connector 76 (also referred to herein as a second connector), which is configured to interface with the field generator connector 52. Two wires 78 extend from the serial data transceiver 64, and they provide a serial data communication pathway for the DTA 42 to accept from the field generator 40 data related to treatment of the patient using TTFields therapy. These wires 78 terminate in electrical connection pins (not illustrated) in the DTA connector 76 which mate with the corresponding pins of the field generator connector 52.
One example of using the hardware depicted in
Once the field generator 40 has been disconnected from the DTA 42, the field generator 40 may be restarted and the transducer arrays connected to it (S94) by connecting the second connector 26 of the transducer interface 20 to the field generator connector 52, as illustrated in
Additionally, once the field generator 40 has been disconnected from the DTA 42—and only after the field generator 40 has been disconnected from the DTA 42—the DTA 42 will begin to transmit the TTFields therapy-related data that it has received from the field generator 40 to a remote server. By not transmitting the TTFields-related data until after the field generator 40 has been disconnected from the DTA 42, isolation of the field generator 40—and hence the overall TTFields therapy treatment system—can be maintained. Thus, this arrangement protects the patient. Additionally, it avoids having to certify the TTFields treatment system as a data communications device in addition to being certified as a medical device.
Once the DTA 42 has transmitted all the received TTFields treatment-related data to the remote server, an indicator (e.g., an LED) illuminates (S98), and the DTA 42 may be turned off (S100).
Some examples of suitable operational logic for the field generator 40 and DTA 42 are illustrated in
At a general level, operational logic of the DTA 42 (shown in
On the other hand, if a device is connected to the DTA 42, flow proceeds to step S105 where the DTA 42 determines whether the connected device is the field generator 40. If the connected device is not the field generator 40 (result path 107), an error message is sent (S270) and the process terminates. Otherwise, the DTA 42 requests (S109) TTFields therapy-related data from the field generator 40, then accepts and stores the data (S111) in its onboard memory 66. Each time the DTA 42 receives data from the field generator 40, the DTA 42 queries (S113) as to whether there is any more data to be transferred. So long as data remains in the field generator 40 to be transferred to the DTA 42 (result path 115), the DTA 42 will continue to accept and store data from the field generator 40.
Once all data has been transferred from the field generator 40 to the DTA 42 (result path 117), the DTA 42 determines whether the field generator 40 has been disconnected from the DTA 42 (S119). If the field generator 40 has not been disconnected from the DTA 42 (result path 121), it prompts the user to disconnect the field generator (S123). On the other hand, once the field generator 40 has been disconnected from the DTA 42 (result path 125), the DTA 42 uploads the data it has received from the field generator 40 to a remote server (S127).
Operational logic for the field generator 40 (shown in
If the connected device is a set of transducer arrays 10 (result path 139), the field generator 40 provides AC voltage to the transducer arrays 10 to provide TTFields therapy to the patient (S141), storing TTFields therapy-related data in its memory 50 as it does so. On the other hand, if the connected device is a DTA 42 (result path 143), the field generator 40 retrieves stored TTFields therapy-related data from its memory 50 and transfers the retrieved data to the DTA 42 (S145), for subsequent uploading by the DTA 42 to the remote server.
Meanwhile, once the power-on self-test in the DTA 42 is completed, the DTA checks (S110) to determine whether there is enough memory available in the DTA 42 (e.g., in EEPROM 66 and/or in an SD card inserted into the flash memory reader/writer 68) to receive and store a complete set of TTFields therapy-related data from the field generator 40. If enough memory is not available in the DTA 42 (i.e., result path 112), then the routine will proceed to the remote-communication portion of the process where an Internet connection is opened (S196,
At this point in the process, the DTA 42 will start to evaluate whether another device is connected to the DTA 42 and, if so, whether the other device is recognized to be the field generator 40 (S118). One suitable approach for making this evaluation is for the DTA 42 to use (a) a switch that actuates upon physical connection of another device to the DTA 42, and (b) a sensor configured to detect that the field generator is powered on. Once the switch and sensor indicate that the field generator 40 has been connected to the DTA 42, the DTA 42 will begin listening for connection requests from the field generator 40.
If a connected device is not recognized to be the field generator 40 (result path 120), the DTA 42 will continue to try to identify the connected device until a predetermined timeout period is reached. If the timeout period is reached (i.e., result path 122), an error message is displayed (S124) and the process terminates. On the other hand, if a connected device is determined to be the field generator 40 (result path 126), then the DTA 42 attempts to establish a data-transmitting connection (S128) between it and the field generator 40—i.e., between the serial data transceiver 64 in the DTA 42 and the serial data transceiver 48 in the field generator 40—by sending a connection request to the field generator 40.
When the field generator 40 receives a connection request from another device (S130), the field generator 40 will determine (S132), e.g., from received data, which device is connected. If the connected device is a set of transducer arrays (result path 134), connected to the field generator 40 by the transducer interface 20, then the field generator 40 will wait for TTFields therapy to be initiated (S136). Once the patient initiates TTFields therapy (not indicated in
The field generator 40 will continue trying to connect to the DTA 42 until a predetermined timeout period, started when the DTA 42 sends the connection request (S128), is reached. If the timeout period is reached (i.e., result path 142), an error message is displayed (S124) and the process terminates.
On the other hand, if the field generator 40 successfully completes the data-transferring connection before the timeout period expires (result path 146), the DTA 42 will initiate the transfer of TTFields therapy-related data (S148) from the field generator 40—i.e., from memory 50—to its own memory, i.e., to EEPROM 66. To do so, the DTA 42 sends a query to the field generator 40 to determine whether any TTFields therapy-related data that has not been transmitted to the DTA 42 remains within memory 50 (S150). If non-transmitted TTFields therapy-related data is present within memory 50 (result path 152), the DTA 42 sends a request to the field generator 40 for the field generator 40 to send TTFields therapy related data to the DTA 42 (S154), and the field generator 40 responds by transmitting TTFields therapy-related data to the DTA 42 (S156).
The DTA 42 processes the incoming TTFields therapy-related data (S158), copies it to EEPROM 66 (S160), and then validates the data (S162). If the data is not valid (result path 164), an error is indicated (S166) and the process terminates. Otherwise, if the data is valid (result path 168), the process returns to check once more whether any non-transmitted TTFields therapy-related data remains within memory 50 (S150).
Once there is no more non-transmitted TTFields therapy-related data remaining within memory 50 (result path 170,
Next, the DTA 42 initiates the data-clearing process (S176) and sends a command to the field generator 40 (S178) instructing the field generator 40 to clear its memory 50 of TTFields therapy-related data. In response to this command, the field generator 40 clears its memory 50 of TTFields therapy-related data (S180) and, upon completion of the clearing step, sends an acknowledgment message back to the DTA 42 (S182) indicating that it (the field generator 40) has done so.
Upon receipt of the acknowledgement message, the DTA 42 turns off its serial data transceiver 64 (S184) to close communication with the field generator 40. The DTA 42 then checks (S186) to determine whether the field generator 40 has been disconnected from the DTA (e.g., using the switch that actuates upon physical connection of another device to the DTA). The DTA 42 will continue checking whether the field generator 40 has been disconnected from the DTA 42 so long as the field generator 40 remains connected to the DTA 42 (result path 188) and until a timeout period—initiated when the DTA 42 receives the data-cleared acknowledgment message and turns off its serial data transceiver 64—expires.
If the timeout period expires (result path 190), the DTA indicates an error (S192), e.g., by lighting an LED or displaying a message instructing the patient to disconnect the field generator 40 from the DTA 42, and all terminate processing without transmitting any data that has been previously accepted. On the other hand, once the field generator 40 has been disconnected from the DTA 42 (result path 194) the DTA will begin to transmit the TTFields therapy-related data that it has received from the field generator 40 to a remote data center server. It should be noted that the DTA 42 will never initiate a communication session with the server while the DTA remains connected to the field generator 40.
After the DTA 42 has been disconnected from the field generator 40, the DTA 42 will open a communication connection (S196) for either the onboard Internet modem 70 or cellular data modem 72, depending on which type of modem the DTA 42 has. (If the DTA 42 has both an Internet modem and a cellular data modem, the DTA 42 could be configured to allow the patient to select which mode of data communication is utilized.) The data-upload process is then begun (S198) by sending a connection request (S200) to a server at the data center.
Upon receipt of the connection request, the server will attempt to authenticate it (S202). If the connection request is not authenticated (result path 204), the connection will be refused (S206) and an error message will be displayed on the DTA 42. On the other hand, if the connection request is authenticated (result path 208), the remote server will send a message to the DTA 42 (S210) accepting the connection request.
Once the DTA 42 receives the message indicating that the connection request has been accepted, it checks (S212) whether any TTFields therapy-related data is in its memory 66 that has not yet been uploaded to the data center. If there is no remaining data to be uploaded (result path 214), the communications connection is closed (S216), and the TTFields therapy-related data stored in the DTA's memory 66 is cleared (S218). The process then returns (path 220,
Upon receipt of the data packet, the remote server validates the incoming data packet (S228). If the incoming data packet is not valid (result path 230), the remote server sends an error message to the DTA 42 (S232), and the DTA displays a communications error indicator (S234). On the other hand, if the incoming data packet is, in fact, valid (result path 236), the remote server examines the packet (S238) to see whether it is the last packet in the transmission of a given unit of data. If the received packet is not the last packet (result path 240), the remote server will send a message to the DTA 42 (S242) acknowledging receipt of the data packet, and the DTA 42 will again check to see (S212) whether any non-transmitted data remains in its memory 66. So long as unsent data remains (result path 224), the DTA 42 will continue to send data packets to the remote server.
When a received packet is the last packet in the transmission of a given unit of data (result path 246), the remote server finalizes the data (S248) by assembling the packets, and it then attempts to validate the assembled data (S250). If the assembled data is not valid (result path 252), the remote server will send an error message to the DTA 42 (S232), and the DTA 42 will display a communication error indicator (S234). On the other hand, if the assembled data is, in fact, valid (result path 258), it will be added to a database on the remote server (S260). The remote server then sends a message to the DTA 42 (S242) acknowledging receipt of the data packet, and the DTA 42 will once again check to see (S212) whether any non-transmitted data remains in its memory 66.
This process will repeat until there is no more non-transmitted data remaining in the memory 66 of the DTA 42 (result path 214). When this point is reached, the data-transmitting connection to the remote server is closed (S216) and TTFields therapy-related data is cleared (S218) from the memory 66 of the DTA 42. The process then returns (path 220,
While the present invention has been disclosed with reference to certain embodiments, numerous modifications, alterations, and changes to the described embodiments are possible without departing from the sphere and scope of the present invention, as defined in the appended claims. Accordingly, it is intended that the present invention not be limited to the described embodiments, but that it has the full scope defined by the language of the following claims, and equivalents thereof.
This Application is a divisional of U.S. application Ser. No. 16/846,672, filed Apr. 13, 2020, which claims the benefit of U.S. Provisional Application 62/835,147, filed Apr. 17, 2019, each of which is incorporated herein by reference in its entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 5233987 | Fabian et al. | Aug 1993 | A |
| 6868289 | Palti | Mar 2005 | B2 |
| 7016725 | Palti | Mar 2006 | B2 |
| 7089054 | Palti | Aug 2006 | B2 |
| 7136699 | Palti | Nov 2006 | B2 |
| 7333652 | Palti | Feb 2008 | B2 |
| 7467011 | Palti | Dec 2008 | B2 |
| 7519420 | Palti | Apr 2009 | B2 |
| 7565205 | Palti | Jul 2009 | B2 |
| 7565206 | Palti | Jul 2009 | B2 |
| 7599745 | Palti | Oct 2009 | B2 |
| 7599746 | Palti | Oct 2009 | B2 |
| 7706890 | Palti | Apr 2010 | B2 |
| 7715921 | Palti | May 2010 | B2 |
| 7805201 | Paiti | Sep 2010 | B2 |
| 7890183 | Palti et al. | Feb 2011 | B2 |
| 7912540 | Palti | Mar 2011 | B2 |
| 7917227 | Palti | Mar 2011 | B2 |
| 8019414 | Palti | Sep 2011 | B2 |
| 8027738 | Palti | Sep 2011 | B2 |
| 8170684 | Palti | May 2012 | B2 |
| 8175698 | Palti et al. | May 2012 | B2 |
| 8229555 | Palti | Jul 2012 | B2 |
| RE43618 | Palti | Aug 2012 | E |
| 8244345 | Palti | Aug 2012 | B2 |
| 8406870 | Palti | Mar 2013 | B2 |
| 8447395 | Palti et al. | May 2013 | B2 |
| 8447396 | Palti et al. | May 2013 | B2 |
| 8465533 | Palti | Jun 2013 | B2 |
| 8706261 | Palti | Apr 2014 | B2 |
| 8715203 | Palti | May 2014 | B2 |
| 8718756 | Palti | May 2014 | B2 |
| 8764675 | Palti | Jul 2014 | B2 |
| 9023090 | Palti | May 2015 | B2 |
| 9023091 | Palti | May 2015 | B2 |
| 9039674 | Palti et al. | May 2015 | B2 |
| 9056203 | Palti et al. | Jun 2015 | B2 |
| 9440068 | Palti et al. | Sep 2016 | B2 |
| 9655669 | Palti et al. | May 2017 | B2 |
| 9750934 | Palti et al. | Sep 2017 | B2 |
| 9910453 | Wasserman et al. | Mar 2018 | B2 |
| 10188851 | Wenger et al. | Jan 2019 | B2 |
| 10441776 | Kirson et al. | Oct 2019 | B2 |
| 11191956 | Giiadi et al. | Dec 2021 | B2 |
| 20060167499 | Palti | Jul 2006 | A1 |
| 20070191912 | Fischer et al. | Aug 2007 | A1 |
| 20070225766 | Palti | Sep 2007 | A1 |
| 20070239213 | Palti | Oct 2007 | A1 |
| 20090076366 | Palti | Mar 2009 | A1 |
| 20090182394 | Bachinski | Jul 2009 | A1 |
| 20120283726 | Palti | Nov 2012 | A1 |
| 20140330268 | Palti et al. | Nov 2014 | A1 |
| 20170120041 | Wenger et al. | May 2017 | A1 |
| 20170215939 | Palti et al. | Aug 2017 | A1 |
| 20170281934 | Giladi et al. | Oct 2017 | A1 |
| 20180001075 | Kirson et al. | Jan 2018 | A1 |
| 20180008708 | Giladi et al. | Jan 2018 | A1 |
| 20180050200 | Wasserman et al. | Feb 2018 | A1 |
| 20180160933 | Urman et al. | Jun 2018 | A1 |
| 20180202991 | Giladi et al. | Jul 2018 | A1 |
| 20190117956 | Wenger et al. | Apr 2019 | A1 |
| 20190117963 | Travers et al. | Apr 2019 | A1 |
| 20190307781 | Krex et al. | Oct 2019 | A1 |
| 20190308016 | Wenger et al. | Oct 2019 | A1 |
| 20190314631 | Wong | Oct 2019 | A1 |
| 20200001069 | Kirson et al. | Jan 2020 | A1 |
| 20200009376 | Chang et al. | Jan 2020 | A1 |
| 20200009377 | Chang et al. | Jan 2020 | A1 |
| 20200016067 | Gotlib et al. | Jan 2020 | A1 |
| 20200023179 | Bomzon et al. | Jan 2020 | A1 |
| 20200061360 | Hagemann et al. | Feb 2020 | A1 |
| 20200061361 | Hagemann et al. | Feb 2020 | A1 |
| 20200069937 | Naveh et al. | Mar 2020 | A1 |
| 20200078582 | Alon et al. | Mar 2020 | A1 |
| 20200108031 | Borst et al. | Apr 2020 | A1 |
| 20200121728 | Wardak et al. | Apr 2020 | A1 |
| 20200129761 | Bomzon et al. | Apr 2020 | A1 |
| 20200146586 | Naveh et al. | May 2020 | A1 |
| 20200155835 | Wasserman et al. | May 2020 | A1 |
| 20200171297 | Kirson et al. | Jun 2020 | A1 |
| 20200179512 | Giladi et al. | Jun 2020 | A1 |
| 20200219261 | Shamir et al. | Jul 2020 | A1 |
| 20200368525 | Maag et al. | Nov 2020 | A1 |
| 20210031031 | Wasserman et al. | Feb 2021 | A1 |
| 20210038584 | Voloshin-Sela | Feb 2021 | A1 |
| 20210060334 | Avraham et al. | Mar 2021 | A1 |
| 20210069503 | Tran et al. | Mar 2021 | A1 |
| 20210187277 | Wasserman et al. | Jun 2021 | A1 |
| 20210196348 | Wasserman | Jul 2021 | A1 |
| 20210199640 | Patel et al. | Jul 2021 | A1 |
| 20210203250 | Wasserman | Jul 2021 | A1 |
| 20210268247 | Story et al. | Sep 2021 | A1 |
| 20210299440 | Deslauriers et al. | Sep 2021 | A1 |
| 20210308446 | Alon et al. | Oct 2021 | A1 |
| 20210330950 | Hagemann et al. | Oct 2021 | A1 |
| 20210346694 | Wasserman et al. | Nov 2021 | A1 |
| 20210379362 | Smith et al. | Dec 2021 | A1 |
| 20210408383 | Kalra et al. | Dec 2021 | A1 |
| Number | Date | Country |
|---|---|---|
| 0801959 | Oct 1997 | EP |
| 2011047211 | Apr 2011 | WO |
| 2018033842 | Feb 2018 | WO |
| 2018156804 | Aug 2018 | WO |
| Entry |
|---|
| Extended European Search Report issued in application No. EP 21193671 dated Jan. 26, 2022. |
| International Search Report and Written Opinion issued in application No. PCT/IB2020/053472 dated Aug. 28, 2020. |
| Partial International Search Report and Written Opinion issued in application No. PCT/IB2020/053472 dated Jul. 7, 2020. |
| Number | Date | Country | |
|---|---|---|---|
| 20220184392 A1 | Jun 2022 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62835147 | Apr 2019 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 16846672 | Apr 2020 | US |
| Child | 17686542 | US |
